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Relapse to maladaptive eating habits during dieting is often provoked by stress and there is evidence for a role of ovarian hormones in
stress responses and feeding. We studied the role of these hormones in stress-induced reinstatement of food seeking and medial prefrontal
cortex (mPFC) neuronal activation in c-fos-GFP transgenic female rats, which express GFP in strongly activated neurons. Food-restricted
ovariectomized or sham-operated c-fos-GFP rats were trained to lever-press for palatable food pellets. Subsequently, lever-pressing was
extinguished and reinstatement of food seeking and mPFC neuronal activation was assessed after injections of the pharmacological
stressor yohimbine (0.5–2 mg/kg) or pellet priming (1–4 noncontingent pellets). Estrous cycle effects on reinstatement were also
assessed in wild-type rats. Yohimbine- and pellet-priming-induced reinstatement was associated with Fos and GFP induction in mPFC;
both reinstatement andneuronal activationwereminimally affectedbyovarianhormones inboth c-fos-GFPandwild-type rats. c-fos-GFP
transgenic ratswere then used to assess glutamatergic synaptic alterationswithin activatedGFP-positive andnonactivatedGFP-negative
mPFC neurons following yohimbine-induced reinstatement of food seeking. This reinstatement was associated with reduced AMPA
receptor/NMDA receptor current ratios and increased paired-pulse facilitation in activated GFP-positive but not GFP-negative neurons.
While ovarian hormones do not appear to play a role in stress-induced relapse of food seeking in our rat model, this reinstatement was
associated with unique synaptic alterations in strongly activated mPFC neurons. Our paper introduces the c-fos-GFP transgenic rat as a
new tool to study unique synaptic changes in activated neurons during behavior.
Introduction
High rate of relapse tomaladaptive eating habits during dieting is
the main problem for treating excessive eating (Kramer et al.,
1989; Peterson andMitchell, 1999). While clinical evidence indi-
cates that this relapse is often provoked by stress, anxiety, or
negative mood states (Grilo et al., 1989; Polivy and Herman,
1999), the neural mechanisms are largely unknown (Nair et al.,
2009a). We adapted a rat reinstatement model, commonly used
to study drug relapse (Shaham et al., 2003), and used the phar-
macological stressor yohimbine to investigate mechanisms of
stress-induced relapse to palatable food seeking during dieting.
Yohimbine is an-2 adrenoceptor antagonist that induces stress-
and anxiety-like states in humans and nonhumans (Bremner et
al., 1996a,b) and reliably reinstates food and drug seeking in rats
(Shepard et al., 2004; Feltenstein and See, 2006; Ghitza et al.,
2006; Richards et al., 2008). Yohimbine-induced reinstatement
of food and drug seeking depends on activation of the stress
neurohormone corticotropin-releasing factor (Ghitza et al.,
2006; Marinelli et al., 2007).
Women may be more vulnerable to stress-induced relapse to
unhealthy eating habits due to menstrual cycle-related fluctua-
tions in ovarian hormones. The proportion of women who use
dietary supplements and seek dietary treatment is more than
twice that ofmen (Davy et al., 2006; Pillitteri et al., 2008). There is
evidence for sex differences and for a role of ovarian hormones in
food intake (Nance, 1983; Geary and Asarian, 1999) and rein-
statement of drug seeking (Carroll et al., 2004; Lynch, 2006;
Becker and Hu, 2008). However, while yohimbine reliably rein-
states food seeking in female rats (Pickens et al., 2012), the role of
ovarian hormones in this reinstatement is unknown. Here, we
assessed yohimbine-induced reinstatement of food-seeking in
ovariectomized (lower than normal physiological levels of es-
tradiol) and sham-operated (normal physiological levels of
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estradiol) rats. Additionally, to determine whether natural fluc-
tuations in ovarian hormones impact yohimbine-induced rein-
statement, we tested cycling female rats during the estrous
(declining estradiol) and diestrous phases (rising estradiol) of the
estrous cycle (Anzalone et al., 2001). Using these experimental
manipulations, we also assessed the role of ovarian hormones in
reinstatement induced by pellet priming (noncontingent pellet
delivery during testing), a manipulation known to reinstate food
seeking (de Wit, 1996).
We recently reported that yohimbine-induced activation of
dorsal medial prefrontal cortex (mPFC) neurons plays a critical
role in yohimbine-induced reinstatement of food seeking inmale
rats (Nair et al., 2011). Therefore, we studied the role of ovarian
hormones in yohimbine-induced mPFC neuronal activation, as
well as synaptic physiology of these activatedmPFC neurons. For
this purpose, we used our newly developed c-fos-GFP transgenic
rats (see Materials and Methods) that contain a transgene with
the c-fos promoter (Morgan and Curran, 1991) that induces
rapid transcription of the gfp coding sequence in response to
strong neuronal activation (Barth et al., 2004). Strongly acti-
vated neurons in these rats can be identified by their GFP
expression in electrophysiological slice preparations to com-
pare synaptic properties of activated (GFP-positive) neurons
and nearby nonactivated (GFP-negative) neurons. We report
that yohimbine-induced reinstatement of food seeking is as-
sociated with unique synaptic plasticity changes that are in-
duced selectively within mPFC neurons that are strongly
activated during the reinstatement test.
Materials andMethods
Subjects and apparatus
Female Long–Evans c-fos-GFP transgenic (n 40) or wild-type (n 8)
rats (NIDA breeding program; 175–275 g) were maintained on a reverse
12 h light/dark cycle (lights off at 7:30 or 8:00 A.M.). All procedures
followed guidelines outlined in the “Principles of laboratory animal care”
(NIH publication no. 85-23). Experiments were conducted in standard
self-administration chambers (Med Associates). Each chamber had two
levers 9 cm above the floor, but only one lever (the “active,” retractable
lever) activated the pellet dispenser, which delivered 45 mg food pellets
containing 12.7% fat, 66.7% carbohydrate and 20.6% protein (catalog #
1811155, TestDiet). This pellet type was chosen based on pellet prefer-
ence tests in food-restricted female rats, using 6 pellet types (obtained
from TestDiet and Bio-Serv) with different compositions of fat (0–35%)
and carbohydrate (45% to 91%) and different flavors (no flavor, banana,
chocolate, grape). All rats wereweighed daily and food-restricted to 9–11
g/d of Purina rat chow (55–65% of their daily food intake) during the
training phase and 14–16 g/d (to maintain stable body weight) during
the extinction and reinstatement test phases; the rat chowwas given after
the daily self-administration sessions. The chronic diet condition was
chosen because human studies suggest that dietary restraint leads to
increased vulnerability to stress-induced food craving and relapse to pal-
atable food intake (Herman and Polivy, 1975; Polivy and Herman, 1999;
Polivy et al., 2005).
Generation of the c-fos-GFP transgenic rats
Transgenic c-fos-GFP transgenic rats contain the same transgene as the
c-fos-GFPmice described byBarth et al. (2004). The c-fos-gfpplasmidwas
a gift fromDr. Alison Barth, CarnegieMellonUniversity, Pittsburgh, PA.
The HindIII-KpnI fragment containing the cfos-gfp transgene was in-
jected into pronuclei of fertilized eggs obtained from Long–Evans fe-
males. Three founders of 28 pups were genotype-positive for the cfos-gfp
transgene. Two of these founders did not provide pups; thus all results in
the present study were obtained from the remaining founder. Tail sam-
ples were genotyped at Laragen Inc using eGFP primers (eGFP forward:
GACCCTGAAGTTCATCTGCACC and eGFP reverse: CGGGTCTTG-
TAGTTGCCGTC) and control primers (1260_1a: CCAGACAGCCAC-
CTATGAAGACAT and 1260_2: CCTTCAGCAAGAGCTGGGGAC).
All subsequent breeding used hemizygous cfos-GFPmale rats paired with
wild-type Long–Evans female rats obtained from Charles River Labora-
tories. Experimental rats were 5–8 generations from the founder.
Ovariectomy surgery and estrous cycle assessment
Rats in Experiment 1 were anesthetized with intraperitoneal injections of
a mixture of sodium pentobarbital and chloral hydrate (60 and 25 mg/
kg). A small 0.6 cm incision was made on the rat’s lower-right abdomen,
through the skin, connective tissue and muscle. The ovary, fallopian
tube, upper uterine horn and associated fat pad were exteriorized. The
uterine artery was tied off with a 3.0 silk suture before the ovary was cut
away and discarded. The muscle wall was then closed with 3.0 chromic
suture followed by closure of the skin layer with Polyglactin 910 (Vicryl).
The procedure was then repeated on the left side. After surgery, rats were
given subcutaneous injections of 2 ml of saline to replace lost fluid and
then the analgesic buprenorphine (0.1 mg/kg, s.c.) was injected 30 min
later. Rats were allowed to recover for at least 7 d and external sutures
were removed by postsurgery day 14.
The nonoperated rats in Experiment 2 underwent a daily vaginal swab-
bing procedure (between 8:00 and 9:00 A.M.) to determine their estrous
cycle phase. A cotton swab dipped in sterile water was gently inserted into
each rat’s vagina and the collected cells were transferred onto a glass slide
for staining/visualization. Estrous cycle phase was determined using es-
tablished guidelines (Goldman et al., 2007). Briefly, the estrous phasewas
defined by a predominance of keratinized (i.e., cornified) cells in the
smear, the diestrous phase was defined by a predominance of leukocytes,
and the proestrous phase by the presence of clusters or strands of round,
nucleated, granular appearing epithelial cells. On reinstatement test days
only, the rats were swabbed a second time immediately after the test
session to confirm their estrous cycle phase during testing. We did not
assess reinstatement during the proestrous phase, because we could not
verify its existence both before and after the reinstatement test (3.5–4 h
apart) in all experimental conditions, resulting in too many missing val-
ues for performing a meaningful statistical analysis.
Drugs
Yohimbine hydrochloride was purchased from Sigma and dissolved in
sterile water. Yohimbine doses are based on previous studies (Ghitza et
al., 2007; Nair et al., 2008, 2009b; Pickens et al., 2012) and a pilot study
with the transgenic c-fos-GFP female rats.
GFP quantification
All procedures described below were performed at room temperature
unless specified. Ninety minutes after the start of the test sessions (120
min after yohimbine injections), rats were deeply anesthetized with iso-
flurane (saturated in air) for 80 s and perfused transcardially with 100ml
of 0.01 M PBS followed by 400 ml of 4% paraformaldehyde in 0.1 M
sodium phosphate, pH 7.4. Brains were removed, postfixed in 4% para-
formaldehyde for 2 h, and transferred to 30% sucrose in 0.01 M sodium
phosphate, pH 7.4, for 48 h at 4°C. Brains were subsequently frozen in
powdered dry ice and stored at80°C until sectioning. Thirty m cor-
onal sections containing the dorsal and ventral mPFC (2.28–3.72
mm, from bregma) (Paxinos and Watson, 2005) were cut in a cryostat
(LeicaMicrosystems Inc.), collected in cryoprotectant (20% glycerol and
2% dimethyl sulfoxide in 0.1 M sodium phosphate, pH 7.4) and stored at
80°C until further processing. Free-floating sections were washed 3
10 min in PBS, mounted onto chrom-alum/gelatin-coated slides, air-
dried and coverslipped with Vectashield fluorescent mounting medium
(H-1400, Vector Labs). Fluorescent images of the dorsal and ventral
mPFC were digitally captured using a Qimaging Exi Aqua camera at-
tached to a Zeiss Axioskop 2 microscope with a 5 objective. GFP-
positive nuclei in 1–2 sections of each left and right hemisphere from
each rat were automatically counted using iVision MacOS 10.6.2 (ver-
sion 4.0.15) (BioVision Technologies). GFP fluorescence images were
pseudocolored green. Image capture and quantification of GFP-positive
nuclei were conducted in a blind manner by C.C. and N.J.M.
Fos immunohistochemistry
Immunohistochemical procedures were based on our previous studies
(Koya et al., 2009; Bossert et al., 2011, 2012; Nair et al., 2011). Immuno-
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labeling for Fos (the protein product of the immediate early gene c-fos)
was used to identify and quantify Fos expressed in dorsal and ventral
mPFC neurons during the reinstatement tests. Sections were thawed and
washed 3 10 min in PBS, incubated for 1 h in 3% normal goat serum
(NGS) in PBS with 0.2% Triton X-100 (PBS-Tx), and incubated over-
night at 4°C with anti-Fos primary antibody (sc-52, Lot I2209, Santa
Cruz Biotechnology) diluted 1:4000 in 1%NGS in PBS-Tx. Sectionswere
then washed in PBS and incubated for 2 h with biotinylated anti-rabbit
IgG secondary antibody (BA-1000, Vector Labs) diluted 1:600 in 1%
NGS in PBS-Tx. Sections were washed in PBS and incubated in avidin-
biotin-peroxidase complex (ABC Elite kit, PK-6100, Vector Laborato-
ries) in PBS containing 0.5% Triton X-100 for 1 h and washed in PBS.
Sectionswere developed inDAB for4min,washed in PBS,mounted onto
chrom-alum/gelatin-coated slides and air-dried. The slideswere dehydrated
throughagraded seriesof alcohol (30, 60, 90, 95, 100, 100%ethanol), cleared
with Citrasolv (Fisher Scientific), and coverslippedwith Permount (Sigma).
Bright-field images of the dorsal and ventral mPFC were digitally captured
using a Qimaging camera attached to a Zeiss Axioskop 2microscope with a
5 objective. Labeled Fos-immunoreactive nuclei in 1–2 sections of each
left and right hemisphere fromeach ratwere automatically counted using
iVisionMacOS 10.6.2 (version 4.0.15). Image capture and quantification
of Fos-IR nuclei were conducted in a blind manner by C.C. and N.J.M.
The number ofGFP-positive, Fos-IR andGFP-IRnuclei in the dorsal and
ventral mPFC was determined by calculating the mean value of two
hemispheres per rat.
Yohimbine time course and double-labeling
immunohistochemistry of Fos and GFP
Three female c-fos-GFP rats were injected with yohimbine (2mg/kg, i.p.)
and perfused 2 h after the injections. The mPFC of these rats was sec-
tioned on a cryostat as described above. Sections were then thawed and
washed 3  10 min in Tris-buffered saline (TBS), incubated for 1 h in
10%NGS in TBS with 0.2% Triton X-100 (TBS-Tx), and then incubated
in 2% NGS in TBS-Tx overnight at 4°C with rabbit anti-Fos primary
antibody (sc-52, Lot D1411, Santa Cruz Biotechnology) diluted 1:500,
and chicken anti-GFP primary antibody (GFP-1020, lot 1229FP08, Aves
Labs Inc) diluted 1:1000. To detect both GFP-IR and Fos-IR, sections
were washed in TBS and incubated for 2 h in 2% NGS in TBS-Tx with
biotinylated donkey anti-chicken IgG antibody (703–065-155, Jackson
ImmunoResearch) diluted 1:200 and then washed in TBS and incubated
for another 2 h in 2% NGS in TBS-Tx with Alexa Fluor 350-conjugated
streptavidin (S11249, Invitrogen) diluted 1:200, and Alexa Fluor 568-
conjugated goat anti-rabbit IgG antibody (A11011, Invitrogen). Sections
were then washed in TBS, mounted onto chrom-alum/gelatin-coated
slides, air-dried, and coverslipped with PermaFluor Aqueous Mounting
Medium (TA-030-FM, Thermo Scientific). Fluorescent images of the
dorsal and ventral mPFC were digitally captured using a Qimaging Exi
AquaCamera attached to aZeiss AxioImagerM.2microscopewith a 10
objective. GFP-IR and Fos-IR fluorescence images were pseudocolored
green and red, respectively. GFP-IR and c-Fos-IR nuclei in 1–2 sections
of each left and right hemisphere from each rat were automatically
counted using iVision Lab software MacOS 10.6.7 (version 4.0.15).
Fifteen additional naive female c-fos-GFP transgenic rats were used for
a time course analysis of Fos-IR and GFP-IR induction after yohimbine
injections. The rats were transferred to a novel cage and a novel roomand
immediately injected with yohimbine (2 mg/kg, i.p.). Subsequently, the
rats were perfused either immediately (0 h), 2, 6, or 24 h (n  3–4 per
time point) after the injections. The assay conditions were the same as
above except that PBS was used instead of TBS.
Radioimmunoassay for corticosterone
A radioimmunoassay for the stress hormone corticosterone was per-
formed to determine the effect of ovariectomy on yohimbine-induced
increases in plasma corticosterone (Suemaru et al., 1989; Marinelli et al.,
2007). At the end of Experiment 1, 1 ml of blood was extracted from the
right atrium of anesthetized rats and transferred into heparin-treated
Microfuge tubes (50l of 5000USPU/ml heparin per tube) immediately
before perfusions for immunohistochemistry. The blood samples were
centrifuged at 800 g for 10 min in a refrigerated Microfuge to separate
plasma from cells. Plasma samples (500 l) were stored at 80°C until
further processing. Corticosterone levels were then assessed using the
radioimmunoassay kit from MP Biomedicals LLC as previously de-
scribed (Shalev et al., 2003). All plasma samples were run in a single assay
using the standard dilution method (samples were diluted 1:200). Mean
intra-assay variance was 5%.
Electrophysiology
Rats received yohimbine (2 mg/kg, i.p.) injections 30 min before the 60
min reinstatement tests. Rats were decapitated immediately after the
reinstatement test (90 min after yohimbine injections) and their brains
were rapidly removed and immersed in near frozen (1–3°C) oxygenated
high-sucrose artificial CSF (aCSF) containing (in mM) 194 sucrose, 30
NaCl, 4.5 KCl, 1 MgCl2, 26 NaHCO3, 1.2 NaH2PO4, and 10 D-glucose
saturated with 95% O2/5% CO2. Control c-fos-GFP transgenic rats and
their negative littermates underwent 5–7 d of food deprivation without
any food self-administration training, and their brains were removed 90
min later after yohimbine injections (2 mg/kg, i.p.) in their home cage.
Coronal slices (280 m) corresponding to 2.4–4.0 mm anterior to
bregma (Paxinos and Watson, 2005) (containing dorsal mPFC) were
prepared using a vibrating tissue slicer (VT1000S; Leica Instruments).
Hemisectioned brain slices were stored in a holding chamber containing
normal aCSF containing (in mM) 126 NaCl, 4.5 KCl, 2.5 CaCl2, 1MgCl2,
26NaHCO3, 1.2 NaH2PO4, and 11 D-glucose for20min at 35°C before
imaging and recording. One brain slice was transferred to a recording
chamber and continuously superfusedwith normal aCSF (2ml/min) and
maintained at 3032°C using a temperature-controlled solution heater
(TC-234B; Warner Instruments).
All recordings were performed in layers 2/3 of the dorsal mPFCwithin
7–8 h after decapitation. Control rats ranged from 10 to 13 weeks old
(mean  SEM age: 11.7  0.5 weeks), while rats for GFP-positive and
GFP-negative neuron recordings ranged from 10 to 22 weeks old
(mean  SEM age: 14.7  0.7 weeks). Brain slices were viewed with an
upright Olympus BX51WI microscope with a water-immersion objec-
tive (40; numerical aperture  0.80; LUMPlan Fl), equipped with a
spinning disk confocal system (PerkinElmer) and near-infrared differen-
tial interference contrast (DIC) imaging capabilities. Confocal and DIC
Imageswere acquiredusinghigh-resolutionCCDcameras (Hamamatsu).A
single brain slice was placed in a submerged perfusion chamber (Warner
Instruments) and confocal imaging of mPFC GFP-positive neurons
commenced. GFP-positive cells were identified under 488 nm laser-light
and images were acquired using Volocity software (PerkinElmer). Neu-
ronal GFP signals were then superimposed on DIC images of the same
neuron. To confirm that the neurons recorded were GFP-positive, an
Alexa Fluor 568 dye (Invitrogen) was included in whole-cell pipettes to
permit colocalization of the GFP and Alexa Fluor 568 signals (see Fig.
4D). GFP and Alexa Fluor 568 fluorescence images were pseudocolored
green and red, respectively. Cells not exhibiting a GFP signal were con-
sidered to be GFP-negative. Data from 1 to 2 GFP-positive and 1–3
GFP-negative cells were obtained from each rat.
Whole-cell recordings of evoked EPSCs in pyramidal neurons of dor-
sal mPFC layers 2/3 were performed using an Axopatch 200B amplifier
(Molecular Devices) and electrodes pulled from borosilicate capillary
glass (1.5 mm outer diameter, 0.86 mm inner diameter). Currents were
measured using pipettes in which the tip was filled with an intracellular
solution containing the following (in mM): 125 K-gluconate, 10 HEPES,
1 EGTA, 2 MgCl2, 0.1 CaCl2, 10 KCl, 2 Mg
2-ATP, 0.2 Na-GTP that
allowed firing patterns of neurons to be studied. The remainder of the
pipette was “back-filled” with a solution containing the following (in
mM): 120 CsMeSO3, 5 NaCl, 10 TEA-Cl, 10 HEPES, 4 QX-314 (Sigma),
1.1 EGTA, 4Mg-ATP, and 0.3 Na-GTP, 0.1MAlexa Fluor 568, with pH
set at 7.2 with CsOH for voltage-clamp studies. Equilibrium between the
back-filledCsMeSO4-containing solution and the tip-filledK-gluconate-
containing intrapipette solution was complete within 15 min of onset of
whole-cell access, as confirmed by the absence of action potentials due to
inclusion of the quaternary lidocaine derivative QX-314 in the back-fill
solution. Pyramidal neurons were identified within the mPFC based on
morphology under DIC microscopy (a prominent apical dendrite) and
by their distinct firing patterns in response to current injections in
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current-clamp mode (e.g., action potential frequency accommodation).
Signals were amplified, filtered at 3–5 kHz, digitized at 10 kHz, and
recorded via on an A/D board (PCI 6024E, National Instruments) and
acquired to a PC hard-drive using Windows-based software (WinWCP,
courtesy of Dr. John Dempster, University of Strathclyde, Glasgow, UK;
http://spider.science.strath.ac.uk/PhysPharm/). Responses were elicited
by stimulation within 100–300 m of the recorded neuron using single
bipolar pulses (0.1 ms duration) at 0.033 Hz, and theta glass pipettes
filled with extracellular solution. Series resistance of the recording was
monitored using 10 mV voltage steps (200 ms) and only cells main-
taining stable access (10% change) were included in the analyses.
EPSCsweremeasured in aCSF-containing picrotoxin (100M, Sigma) to
isolate these currents from GABAA receptor-mediated IPSCs. Neurons
were voltage-clamped at80 mV except where noted. AMPA receptor/
NMDA receptor (AMPAR/NMDAR) current ratios were determined by
obtaining an average waveform from 10 recording sweeps of AMPA
receptor-mediated EPSCs at 80 mV and NMDA receptor-mediated
EPSCs at 40 mV. The peak AMPA receptor EPSC was divided by the
NMDA receptor EPSC,measured 35ms following the peak of the AMPA
receptor EPSCs. We also computed AMPAR/NMDAR current ratios
from the averages of 10 evoked EPSCs at 40 mV with and without
D-APV (50M, Tocris Bioscience) in the aCSF.Mean responses recorded
during D-APV application (AMPA receptor-only EPSC) were digitally
subtracted from responses recorded without D-APV (AMPA receptor
NMDA receptor EPSC) to determine theNMDAREPSC. The peak of the
AMPA receptor EPSC was divided by the peak of the NMDA receptor
EPSC to yield the AMPAR/NMDAR current ratio. Paired-pulse ratios
were performed by delivering stimulus trains at 20, 40, 60, 80, 100, 150,
and 200 ms interstimulus intervals.
Training, extinction, and reinstatement of food-reinforced
responding
The experimental conditions during the training, extinction, and rein-
statement phases were similar to those used in our previous studies in
male and female rats (Nair et al., 2009b, 2011; Pickens et al., 2012).
During all phases, the sessions started 30min after rats were placed in the
self-administration chambers; 8:30 A.M. for the morning group and
12:30 pm for the afternoon group.
Training and extinction phases.During the training phase, we first gave
the rats 3 h daily sessions of “autoshaping” for 2 d during which pellets
were delivered noncontingently every 5 min into a receptacle located
near the active lever. Pellet delivery was accompanied by a compound 5 s
tone (2900 Hz)-light (7.5 W white light) cue, located above the active
lever. Subsequently, we trained the rats to lever-press for the pellets on a
fixed-ratio-1, 20 s timeout reinforcement schedule. At the start of each
3 h session, the red houselight was turned on and the active lever was
extended. Reinforced active lever-presses resulted in the delivery of one
pellet, accompanied by the compound 5 s tone-light cue. Active lever
presses during the 20 s timeout or presses on the inactive lever had no
programmed consequences. During the extinction phase, lever-presses
during the 3 h sessions led to tone-light cue presentations, but not pellet
delivery.
Reinstatement phase. During tests for yohimbine-induced reinstate-
ment, we injected the rats with different yohimbine doses (0.5, 1.0, or 2.0
mg/kg, i.p.) or vehicle (sterile water) 30 min before the start of the test
sessions. During tests for pellet-priming-induced reinstatement, we gave
the rats 1, 2, or 4 noncontingent pellets or no pellets (control condition)
within 1min after the start of the test sessions. The tests for reinstatement
were performed under extinction conditions (lever-presses led to tone-
light cue presentations, but not pellet delivery).
Experiment 1. Effect of ovariectomy on reinstatement of food
seeking and mPFC activation
Experiment 1 included 12 sham and 12 ovariectomized female rats
that were repeatedly tested. We first trained the rats for food self-
administration (5 sessions). We then tested them for the effect of
yohimbine (0, 0.5, 1, and 2 mg/kg, i.p.; counterbalanced order) on
ongoing food-self-administration over 8 sessions; yohimbine/vehicle
injections were given every other day, and regular training sessions
were given in the intervening days. Subsequently, we gave the rats 20
extinction sessions and then tested them for reinstatement under
extinction conditions.
During the reinstatement test sessions, which were performed every
other day with regular extinction sessions in the intervening days, we
injected the rats with vehicle or yohimbine (0.5, 1, and 2 mg/kg, i.p.;
counterbalanced order) or gave them no pellet or pellet priming (1, 2,
and 4; counterbalanced order). After completing the yohimbine- and
pellet-priming-induced reinstatement tests, we gave the ovariectomy
(OVX) and sham groups a final 90 min reinstatement test and extracted
their brains immediately after testing. We divided the rats in each group
into three reinstatement conditions (n 4 per condition): vehicle injec-
tion, yohimbine (2 mg/kg, i.p.) injection, and pellet priming (4 pellets).
The duration of the final reinstatement session was shorter (90 min
instead of 3 h) because of the time course of Fos protein expression,
which is maximal 90–120 min after neuronal activation (Curran and
Morgan, 1995). At the end of testing, the rats were anesthetized and
arterial blood was collected for analysis of plasma corticosterone (see
above). The rats were then perfused and their brains were removed for
quantification of Fos and GFP.
Experiment 2. Role of estrous cycle in yohimbine and pellet
priming-induced reinstatement of food seeking
In this experiment, we further assessed the role of ovarian hormones
in reinstatement of food seeking by determining whether the normal
fluctuations in the levels of these hormones, observed across the es-
trous cycle, would affect yohimbine- or pellet-priming-induced rein-
statement.We used a within-subject design with the factors of Estrous
Phase (estrous, diestrous), Reinstatement Condition (water injec-
tions [control], 2 mg/kg yohimbine, 4 noncontingent pellets), and
Lever (active, inactive). Female rats (n  8) underwent 2 sessions of
autoshaping, 10 training sessions, and 11 extinction sessions, using
procedures described above. Vaginal swabs were performed each
morning to determine the rats’ estrous cycle phase. Following extinc-
tion of food-reinforced responding, we assessed the effect of declining
(estrous phase) or rising (diestrous phase) estradiol levels on
yohimbine-induced and pellet priming-induced reinstatement. The
rats received either water or yohimbine injections (2 mg/kg, i.p.) 30
min before the start of the test sessions, or received 4 pellets at the
beginning of the test session. Each rat was tested a total of 6 times (3
times in estrous and 3 times in diestrous) and underwent at least one
yohimbine-free or pellet-free extinction session between each test.
One rat was excluded due to abnormal estrous cycling during the
experiment (final n  7).
Experiment 3. Synaptic properties of mPFC neurons activated
during yohimbine-induced reinstatement
In this experiment, we used the slice electrophysiology procedure
described above to characterize the phenotype and synaptic proper-
ties of neurons activated during yohimbine-induced reinstatement of
food seeking. We used one group of rats (n 16) that were tested for
yohimbine-induced reinstatement. The female c-fos-GFP transgenic
rats underwent the same training, extinction and reinstatement pro-
cedures described above. Following extinction of food-reinforced re-
sponding, the rats received yohimbine injections (2 mg/kg, i.p.) 30
min before the start of a 60 min test session. Immediately after the test
session, rats were decapitated and their brains were immediately re-
moved and processed for slice electrophysiology.
Statistical analyses
Data were analyzed by ANOVAs using the statistical program SPSS
(GLM procedure), and significant main effects and interaction effects
(p  0.05) were followed by Fisher PLSD post hoc tests. The dependent
measures and the factors used in the statistical analyses are described in
the results section below. Because our multifactorial ANOVAs yielded
multiple main and interaction effects, we only report significant interac-
tion or main effects that are critical for data interpretation.
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Results
Fos and GFP induction in mPFC of c-fos-GFP transgenic
female rats
We initially characterized Fos and GFP induction in mPFC from 3
naive c-fos-GFP transgenic rats. Figure 1A shows representative
Fos-IRandGFP-IRneurons inventral anddorsalmPFCof these rats
perfused 2 h after injections of yohimbine (2mg/kg, i.p.).We found
that, 77% and 79% of GFP-IR neurons in dorsal and ventral mPFC
were Fos-IR positive. These values are similar to our previous cola-
beling results for -galactosidase-IR and Fos-IR in the mPFC of
c-fos-lacZ transgenic rats (Bossert et al., 2011). The less than perfect
colocalization of GFP-IR and Fos-IR neurons is likely due to differ-
ences in antibody sensitivity and the thresholds chosen for each pro-
teinwhendeterminingwhether a nucleus is immunoreactive or not.
We also assessed the time course of Fos and GFP induction in
mPFC after yohimbine injections (Fig. 1B). We injected 15 c-fos-
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GFP female rats with yohimbine (2 mg/kg, i.p.) and perfused them
either immediately (0 h), 2 h, 6 h, or 24 h after the injections. We
found that expression pattern of Fos andGFP showed a similar time
coursewithhigher levels 2or6hafter yohimbine injections than0or
24 h after these injections. Additionally, the proportion of GFP-IR
cells that coexpressed Fos-IR remained constant over time. ANO-
VAs of immunoreactive cell counts of the dorsal and ventral mPFC
showedsignificant effectsofTime forFos-IR(F(3,14)44.3and51.4,
p 0.001, respectively), GFP-IR (F(3,14) 24.1 and 71.4, p 0.001,
respectively), and Fos-IR–GFP-IR double-labeling (F(3,14)  33.5
and 57.1, p 0.001, respectively).
Effect of OVX on reinstatement of food seeking and
mPFC activation
Successful ovariectomy surgery was confirmed by analysis of
postmortemuterineweight: 0.38 0.01 and 0.01 0.002 g in the
sham and OVX groups, respectively, p 0.001 (One uterus was
lost during the postmortem extraction procedure). The success-
ful surgery is also indicated by a significant group differences in
body weight (p 0.001). In the Sham group, mean SEM body
weight before surgery (free-feeding), the first training day (re-
stricted feeding), and the last reinstatement test day (restricted
feeding) was 311 19, 304 16, and 301 11 g, respectively. In
the OVX group, the body weight during these days was 315 8,
352 9, and 348 5 g, respectively. OVX had no effect on pellet
intake during initial training (Fig. 2A), yohimbine-induced in-
creases in pellet intake during training (data not shown), or ex-
tinction of food-reinforced responding (Fig. 2A).
Reinstatement
OVX had no effect on yohimbine-induced reinstatement but de-
creased pellet-priming-induced reinstatement (Fig. 2B,C). The
data were analyzed using the between-subjects factor of OVX
(OVX, Sham) and the within-subjects factors of Lever (active,
inactive) and Yohimbine Dose (0, 0.5, 1, 2mg/kg) or Pellet Prim-
ing (0, 1, 2, 4 pellets). The analysis of the yohimbine data showed
a significant interaction of Yohimbine Dose  Lever (F(3,66) 
23.4, p 0.001). The analysis of the pellet-priming data showed
significant interactions of OVX Lever (F(1,22) 5.9, p 0.024)
and Pellet Priming OVX Lever (F(3,66) 2.9, p 0.043).
mPFC activation
Yohimbine- and pellet-priming-induced reinstatementwas asso-
ciated with increased GFP expression and Fos-IR in the dorsal
and ventral mPFC (Fig. 3). The behavioral data were analyzed
using the between-subjects factors of OVX and Reinstatement
Condition (vehicle, 2 mg/kg yohimbine, 4 pellets), and the
within-subjects factor of Lever. TheANOVA showed a significant
interaction of Reinstatement Condition Lever (F(2,18) 49.5,
p 0.001) (Fig. 3A). Yohimbine-induced reinstatement induced
GFP and Fos expression in the mPFC. Analyses for GFP and Fos
quantification included the between-subjects factors of OVX and
Reinstatement Condition, and the within-subjects factor of
mPFC Region (dorsal, ventral). The ANOVA for the GFP quan-
tification (Fig. 3B) showed a significant effect of Reinstatement
Condition (F(2,18)  20.3, p  0.001), but no effect of mPFC
Region or Reinstatement ConditionmPFC Region (p 0.1).
TheANOVA for the Fos-IR (Fig. 3C) showed significant effects of
Reinstatement Condition  mPFC Region (F(2,17)  19.9, p 
0.001) and Reinstatement Condition  mPFC Region  OVX
(F(2,17) 4.4, p 0.028). These interactions are due to somewhat
higher baseline and yohimbine-induced Fos-IR in dorsal than in
ventral mPFC and somewhat higher Fos expression in the OVX
group than in the Sham group.
Corticosterone
Yohimbine-induced but not pellet priming-induced reinstate-
ment increased plasma corticosterone secretion (p  0.01), a
hormonal measure of the stress response (Selye, 1956), and this
effect was not affected by OVX. Themean SEM values (ng/ml)
in the sham group were 334  58, 344  40, and 788  24 for
vehicle, pellet priming, and yohimbine, respectively (n  4 per
condition). The mean values in the OVX group were 267  37,
310  33, and 587  63 for vehicle, pellet priming, and yohim-
bine, respectively (n 3–4 per condition).
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Figure 2. Effect of yohimbine and pellet priming on reinstatement of food seeking in ovari-
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Role of estrous cycle in yohimbine and pellet
priming-induced reinstatement of food-seeking
Nonoperated female rats (n  7) were trained for 10 consecutive
days (3 h/d) to lever-press for food pellets (mean  SEM pellet
intake over last 4 training days was 191 20 pellets per 3 h). Lever-
pressing was then extinguished over 11 consecutive extinction days
(mean  SEM active lever-presses on the first and last extinction
sessionwere 276114 and165per 3h, respectively). Yohimbine
(2 mg/kg) and pellet priming (4 pellets) reinstated active lever-
pressing after extinction of the food-reinforced responding and this
effect was not dependent on the estrous cycle (Fig. 2D). The data
were analyzedusing thewithin-subjects factors of Estrous Phase (es-
trous, diestrous), Reinstatement Condition (control, 2 mg/kg yo-
himbine, 4 pellets) and Lever. The ANOVA showed significant
Reinstatement Condition  Lever interaction (F(2,12)  13.6, p 
0.001) but not Estrous Phase or interactions between Estrous Phase
and the other factors (p 0.1).
Synaptic properties of mPFC neurons activated during
yohimbine-induced reinstatement
Themean SEMpellet intake over last 4 training dayswas 181
15 pellet per 3 h, n  16. Lever-pressing was then extinguished
during the extinction phase (mean SEMactive lever-presses on
the first and last extinction sessions were 518  118 and 22  4
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per 3 h, respectively). Yohimbine (2 mg/kg, i.p.) reinstated active
lever-pressing after extinction of the food-reinforced responding
(Fig. 4C). The statistical analysis comparing the 60 min
yohimbine-inducedreinstatement testwith theprevious first 60min
of the last extinction session showed a significant effect of Test Ses-
sion (t15 5.9, p 0.001).
We examined glutamate synapses in dorsal mPFC layer 2/3
pyramidal neurons in c-fos-GFP rats. To determine whether syn-
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aptic properties were altered in the transgenic rats, we randomly
selected and recorded from pyramidal neurons in brain slices
from control c-fos-GFP rats andwild-type littermates that did not
undergo food self-administration training thatwere killed 90min
after home-cage yohimbine injections (2 mg/kg, i.p.) using only
DIC microscopy. AMPAR/NMDAR current ratios were mea-
sured, as indicators of changes in synaptic strength (Ungless et al.,
2001) by obtaining peak AMPAR- and NMDAR-mediated
EPSCs at 80 mV and 40 mV, respectively. The AMPAR/
NMDAR current ratios did not differ significantly in randomly
selected dorsal mPFC neurons between c-fos-GFP and wild-type
rats (Fig. 4A, p  0.7). Paired-pulse facilitation, an indicator of
presynaptic alterations was alsomeasured in these groups of neu-
rons (Fig. 4B). Again, no significant effects were observed for the
main effects of GFP expression (p values0.5) and interstimulus
interval (p  0.2), or an interaction between these two factors
(p  0.5). Together, these results indicate that these synaptic
parameters were not altered in randomly selected dorsal mPFC
neurons of c-fos-GFP rats.
To examine the synaptic properties of neurons activated dur-
ing yohimbine-induced reinstatement of food seeking, we per-
formed whole-cell recordings from both activated GFP-positive
and nonactivated GFP-negative pyramidal neurons (Fig. 4D).
We determined AMPAR/NMDAR current ratios by obtaining
peak AMPAR- and NMDAR-mediated EPSCs at 80 mV and
40 mV, respectively (Fig. 4E, top), and by pharmacologically
isolating AMPA and NMDA currents at 40 mV (Fig. 4E, bot-
tom). In both cases, we found significantly lower ratios in GFP-
positive neurons compared with those in GFP-negative neurons
(GFP-positive: 2.83 0.26, GFP-negative: 5.18 0.59; t7 3.3,
p 0.013, Fig. 4E, top; GFP-positive: 0.50 0.06, GFP-negative:
0.74 0.07; t14 2.51, p 0.025, Fig. 4E, bottom), suggesting a
weakening of glutamatergic synaptic strength in GFP-positive
neurons. Analysis of paired-pulse data (Fig. 4F) revealed signifi-
cant effects of Interstimulus interval (F(6,102) 3.7, p 0.0025)
andGFP expression Interstimulus interval (F(6,102) 3.18, p
0.0067). Post hoc analysis revealed significant increases in paired-
pulse facilitation in GFP-positive neurons at an interstimulus
interval of 20 ms compared with GFP-negative neurons (GFP-
positive: 1.30  0.13, GFP-negative: 0.92  0.06; t17  3.4, p 
0.0128, Fig. 4F), suggesting decreased presynaptic glutamate
release.
Discussion
We used c-fos-GFP transgenic female rats to assess the role of
ovarian hormones in relapse to palatable food seeking andmPFC
activation induced by the anxiogenic drug yohimbine, which
induces stress-like states in both non-humans and humans
(Bremner et al., 1996a,b). Our main novel finding is that
yohimbine-induced reinstatement of food-seeking was associ-
ated with unique synaptic alterations in activatedmPFC neurons
that were not observed in nonactivated neurons. Another finding
in our study is that ovarian hormones do not play a major role in
reinstatement of food seeking during dieting in our rat model.
c-fos-GFP transgenic rats
The endogenous c-fos gene is rapidly activated by physiological,
pharmacological, and environmental stimuli and serves as a neu-
ronal activity marker (Morgan and Curran, 1991). The develop-
ment of our c-fos-GFP rats was inspired by the c-fos-GFP mouse
(Barth et al., 2004; Wu et al., 2009) that contains the same trans-
gene with a c-fos promoter that rapidly induces the expression of
a Fos-GFP fusion protein. A unique advantage of these transgenic
rodent models is that the GFP signal can be used to identify
neurons that are activated during behavior.
Here we used GFP to identify mPFC neurons that were acti-
vated during yohimbine-induced reinstatement of food seeking
and to compare glutamatergic synaptic function in these neurons
to that of the nonactivated (GFP-negative) neurons. Compared
with nearby GFP-negative neurons in the mPFC, GFP-positive
neurons exhibited increased paired-pulse facilitation, indicative
of a decrease in synaptic glutamate release (Mennerick and
Zorumski, 1995), and reduced AMPAR/NMDAR current ratios,
which is consistent with a reduction in glutamatergic synaptic
strength (Ungless et al., 2001; Malinow and Malenka, 2002).
Thus, strongly activated mPFC neurons exhibit presynaptic and
postsynaptic alterations at glutamatergic synapses that are not
observed in the majority of nonactivated (or less activated) sur-
rounding neurons.
The increased paired-pulse facilitation and the decreased
AMPAR/NMDAR current ratio may reflect a homeostatic adap-
tation of glutamate synapses (Ishikawa et al., 2009; Wolf and
Ferrario, 2010; Huang et al., 2011) in response to strong acute
activation during the yohimbine-induced reinstatement test. Al-
ternatively, the unique synaptic properties of the GFP-positive
neurons may reflect basal synaptic alterations that occurred dur-
ing food self-administration and extinction of food-reinforced
responding. Regardless of the exact mechanism, our study high-
lights the importance of selectively examining behaviorally acti-
vated neurons by showing that their properties are different from
the surrounding nonactivated (or less activated) GFP-negative
neurons.
To date, studies that have examined acute synaptic plasticity
immediately after reinstatement of reward seeking have been per-
formed in rats (Van den Oever et al., 2008, 2010a). In these stud-
ies, as well as many other drug self-administration studies
(Kalivas, 2009; Bowers et al., 2010; Wolf and Ferrario, 2010; Van
den Oever et al., 2010b), synaptic alterations were observed in a
general population of neurons using whole-cell recordings from
randomly selected cells, regardless of their activation state during
behavior. Thus, information pertaining to behaviorally relevant
strongly activated neurons (as indicated by c-fos expression),
which likely mediates reward seeking (Bossert et al., 2011) could
not be obtained. The c-fos-GFP transgenic rats, as well as the
recently developed c-fos-monomeric red fluorescent protein 1
(mRFP1) transgenic rats (Fujihara et al., 2009), can be used to
provide fundamentally new information on the unique synaptic
alterations of these putative behaviorally relevant neurons.
Role of ovarian hormones in reward seeking
Sex differences and ovarian hormones play a role in food intake
(Nance, 1983; Asarian and Geary, 2006) and drug seeking (Car-
roll et al., 2004; Becker and Hu, 2008), including yohimbine-
induced reinstatement (Anker and Carroll, 2010; Feltenstein et
al., 2011). Amain conclusion from the drug studies is that female
rats are more vulnerable than male rats to the initiation, mainte-
nance, and relapse of drug-seeking behaviors (Lynch, 2006;
Becker andHu, 2008). Based on these findings, and the emerging
neurobiological similarities between palatable food- and drug-
taking behaviors (DiLeone et al., 2003; Johnson andKenny, 2010;
Kenny, 2011), a somewhat surprising finding in our studywas the
minimal impact of ovariectomy on food-reinforced responding
during training, extinction responding, and reinstatement.
In reconciling our data with these previous results, several
issues should be considered. First, studies on the role of ovarian
hormones in food intake have primarily assessed home-cage
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feeding (Geary and Asarian, 1999; Asarian and Geary, 2006) that
likely involves neuronal and psychological mechanisms that are
different from those controlling operant food-seeking behaviors
(Figlewicz et al., 2007; Nair et al., 2009a; Figlewicz and Sipols,
2010). Second, in the case of drug seeking, conclusions regarding
sex differences and the role of ovarian hormones in drug seeking
are primarily based on studies using cocaine. There are differ-
ences between the mechanisms underlying reward and relapse to
cocaine compared with reward and relapse to opiates and other
drugs of abuse (Badiani et al., 2011). Relevant here are the find-
ings that manipulations of ovarian hormones had no effect on
heroin self-administration (Stewart et al., 1996) and that the es-
trous cycle had no effect on yohimbine-induced reinstatement of
nicotine seeking (Feltenstein et al., 2012). Third, in a recent study
we assessed sex differences in food-reinforced responding, ex-
tinction responding, and yohimbine- and pellet-priming-
induced reinstatement, and found no evidence for increased
food-seeking behavior in female rats compared with male rats
(Pickens et al., 2012). Additionally, while comparison across
studies should be made with caution, the magnitude of
yohimbine-induced mPFC Fos expression in the current study
was similar to that we previously observed in male rats (Nair et
al., 2011).
Together, a tentative conclusion from the above studies is that
while ovarian hormones and sex differences play an important
role in vulnerability to cocaine-seeking behaviors, thismay not be
the case for nicotine, opiates, and palatable food.
Methodological considerations
One issue is that the rats were tested repeatedly for both
yohimbine- and pellet-priming-induced reinstatement. How-
ever, it is unlikely that habituation to repeated testing con-
founded data interpretation. Internal analyses of both the present
data and a recent study in which we used a similar repeated mea-
sures design (Pickens et al., 2012) indicate neither habituation
nor sensitization of yohimbine- or pellet-priming-induced rein-
statement over repeated testing.
Another issue is the relatively small sample size in the immu-
nohistochemistry assays and the electrophysiology experiments.
It is unlikely that a larger number of subjects in the immunohis-
tochemistry experiment will change data interpretation. As can
be seen in Figure 3, yohimbine induced reliable increases in Fos
and GFP expression that were of similar magnitude in the ovari-
ectomized and sham-operated rats, which mirrored the behav-
ioral results. The yohimbine-induced Fos expression data are also
in agreement with our findings with nonoperatedmale rats (Nair
et al., 2011), with the exception that the difference between dorsal
(higher) and ventral (lower) mPFC in the female rats was less
pronounced than in the male rats. Similarly, while the numbers
of cells in the GFP-positive and GFP-negative groups in the elec-
trophysiology experiment are relatively low, the data appear ro-
bust with relatively low variability across the cells in each
experimental group. However, an unresolved interpretation is-
sue in the electrophysiology experiment is whether yohimbine-
induced synaptic alterations in mPFC activated neurons are due
to the drug’s effect on the motivation to seek food or are due to
the unconditioned pharmacological effects of yohimbine, which
include stimulation of pyramidal cell firing (Wang et al., 2010).
Concluding remarks
We studied the role of ovarian hormones in stress-induced rein-
statement of food seeking and mPFC activation in c-fos-GFP
transgenic rats, using yohimbine as a pharmacological stressor
and a recently validated rat model (Pickens et al., 2012). Our
main finding is that yohimbine-induced reinstatement of food
seeking was associated with distinct synaptic alterations in acti-
vated GFP-positive versus nonactivated GFP-negative neurons.
Based on these data, we propose that the c-fos-GFP transgenic rat
can be used as a novel tool to study synaptic alterations in acti-
vated neurons following reinstatement of reward seeking and
other learned behaviors that cannot be readily adapted to c-fos-
GFP transgenic mice (Barth et al., 2004; Yassin et al., 2010).
References
Anker JJ, Carroll ME (2010) Sex differences in the effects of allopregnano-
lone on yohimbine-induced reinstatement of cocaine seeking in rats.
Drug Alcohol Depend 107:264–267.
Anzalone CR, Hong LS, Lu JK, LaPolt PS (2001) Influences of age and ovar-
ian follicular reserve on estrous cycle patterns, ovulation, and hormone
secretion in the Long-Evans rat. Biol Reprod 64:1056–1062.
Asarian L, Geary N (2006) Modulation of appetite by gonadal steroid hor-
mones. Philos Trans R Soc Lond B Biol Sci 361:1251–1263.
Badiani A, Belin D, Epstein D, Calu D, Shaham Y (2011) Opiate versus
psychostimulant addiction: the differences do matter. Nat Rev Neurosci
12:685–700.
Barth AL, Gerkin RC, Dean KL (2004) Alteration of neuronal firing prop-
erties after in vivo experience in a FosGFP transgenic mouse. J Neurosci
24:6466–6475.
Becker JB, Hu M (2008) Sex differences in drug abuse. Front Neuroendo-
crinol 29:36–47.
Bossert JM, Stern AL, Theberge FR, Cifani C, Koya E, Hope BT, Shaham Y
(2011) Ventral medial prefrontal cortex neuronal ensembles mediate
context-induced relapse to heroin. Nat Neurosci 14:420–422.
Bossert JM, Stern AL, Theberge FR, Marchant MJ, Wang HL, Morales M,
Shaham Y (2012) Role of projections from ventral medial prefrontal
cortex to nucleus accumbens shell in context-induced reinstatement of
heroin seeking. J Neurosci 32:4982–4991.
Bowers MS, Chen BT, Bonci A (2010) AMPA receptor synaptic plasticity
induced by psychostimulants: the past, present, and therapeutic future.
Neuron 67:11–24.
Bremner JD, Krystal JH, Southwick SM, Charney DS (1996a) Noradren-
ergic mechanisms in stress and anxiety: I. preclinical studies. Synapse
23:28–38.
Bremner JD, Krystal JH, Southwick SM, Charney DS (1996b) Noradrener-
gic mechanisms in stress and anxiety: II. Clinical studies. Synapse 23:
39–51.
Carroll ME, LynchWJ, RothME,Morgan AD, Cosgrove KP (2004) Sex and
estrogen influence drug abuse. Trends Pharmacol Sci 25:273–279.
Curran T,Morgan JI (1995) Fos: an immediate-early transcription factor in
neurons. J Neurobiol 26:403–412.
Davy SR, Benes BA, Driskell JA (2006) Sex differences in dieting trends,
eating habits, and nutrition beliefs of a group of midwestern college stu-
dents. J Am Diet Assoc 106:1673–1677.
de Wit H (1996) Priming effects with drugs and other reinforcers. Exp Clin
Psychopharmacol 4:5–10.
DiLeone RJ, Georgescu D, Nestler EJ (2003) Lateral hypothalamic neuro-
peptides in reward and drug addiction. Life Sci 73:759–768.
Feltenstein MW, See RE (2006) Potentiation of cue-induced reinstatement of
cocaine-seeking in rats by the anxiogenic drug yohimbine. Behav Brain Res
174:1–8.
Feltenstein MW, Henderson AR, See RE (2011) Enhancement of cue-
induced reinstatement of cocaine-seeking in rats by yohimbine: sex dif-
ferences and the role of the estrous cycle. Psychopharmacology 216:
53–62.
Feltenstein MW, Ghee SM, See RE (2012) Nicotine self-administration and
reinstatement of nicotine-seeking in male and female rats. Drug Alcohol
Depend 121:240–246.
Figlewicz DP, Sipols AJ (2010) Energy regulatory signals and food reward.
Pharmacol Biochem Behav 97:15–24.
Figlewicz DP, MacDonald Naleid A, Sipols AJ (2007) Modulation of food
reward by adiposity signals. Physiol Behav 91:473–478.
Fujihara H, Ueta Y, Suzuki H, Katoh A, Ohbuchi T, Otsubo H, Dayanithi G,
Murphy D (2009) Robust up-regulation of nuclear red fluorescent-
tagged Fos marks neuronal activation in green fluorescent vasopressin
Cifani, Koya et al. • c-fos-GFP Transgenic Female Rats and Food Seeking J. Neurosci., June 20, 2012 • 32(25):8480–8490 • 8489
neurons after osmotic stimulation in a double-transgenic rat. Endocri-
nology 150:5633–5638.
Geary N, Asarian L (1999) Cyclic estradiol treatment normalizes body
weight and test meal size in ovariectomized rats. Physiol Behav
67:141–147.
Ghitza UE, Gray SM, Epstein DH, Rice KC, Shaham Y (2006) The anx-
iogenic drug yohimbine reinstates palatable food seeking in a rat relapse
model: a role of CRF(1) receptors. Neuropsychopharmacology
31:2188–2196.
Ghitza UE, Nair SG, Golden SA, Gray SM, Uejima JL, Bossert JM, Shaham Y
(2007) Peptide YY3-36 decreases reinstatement of high-fat food seeking
during dieting in a rat relapse model. J Neurosci 27:11522–11532.
Goldman JM, Murr AS, Cooper RL (2007) The rodent estrous cycle: char-
acterization of vaginal cytology and its utility in toxicological studies.
Birth Defects Res B Dev Reprod Toxicol 80:84–97.
Grilo CM, Shiffman S, Wing RR (1989) Relapse crises and coping among
dieters. J Consult Clin Psychol 57:488–495.
Herman CP, Polivy J (1975) Anxiety, restraint, and eating behavior. J Ab-
norm Psychol 84:66–72.
Huang YH, Schlu¨ter OM, Dong Y (2011) Cocaine-induced homeostatic
regulation and dysregulation of nucleus accumbens neurons. Behav Brain
Res 216:9–18.
Ishikawa M, Mu P, Moyer JT, Wolf JA, Quock RM, Davies NM, Hu XT,
Schlu¨ter OM, Dong Y (2009) Homeostatic synapse-driven membrane
plasticity in nucleus accumbens neurons. J Neurosci 29:5820–5831.
Johnson PM,Kenny PJ (2010) Addiction-like reward dysfunction and com-
pulsive eating in obese rats: role for dopamineD2 receptors. NatNeurosci
13:635–641.
Kalivas PW (2009) The glutamate homeostasis hypothesis of addiction. Nat
Rev Neurosci 10:561–572.
Kenny PJ (2011) Common cellular and molecular mechanisms in obesity
and drug addiction. Nat Rev Neurosci 12:638–651.
Koya E, Golden SA, Harvey BK, Guez-Barber DH, Berkow A, Simmons DE,
Bossert JM, Nair SG, Uejima JL, Marin MT, Mitchell TB, Farquhar D,
Ghosh SC,Mattson BJ,Hope BT (2009) Targeted disruption of cocaine-
activated nucleus accumbens neurons prevents context-specific sensitiza-
tion. Nat Neurosci 12:1069–1073.
Kramer FM, Jeffery RW, Forster JL, Snell MK (1989) Long-term follow-up
of behavioral treatment for obesity: patterns of weight regain amongmen
and women. Int J Obes 13:123–136.
Lynch WJ (2006) Sex differences in vulnerability to drug self-administration.
Exp Clin Psychopharmacol 14:34–41.
Malinow R, Malenka RC (2002) AMPA receptor trafficking and synaptic
plasticity. Annu Rev Neurosci 25:103–126.
Marinelli PW, Funk D, Juzytsch W, Harding S, Rice KC, Shaham Y, Le AD
(2007) The CRF1 receptor antagonist antalarmin attenuates yohimbine-
induced increases in operant alcohol self-administration and reinstate-
ment of alcohol seeking in rats. Psychopharmacology (Berl) 195:345–355.
Mennerick S, Zorumski CF (1995) Paired-pulse modulation of fast excit-
atory synaptic currents in microcultures of rat hippocampal neurons.
J Physiol 488:85–101.
Morgan JI, CurranT (1991) Stimulus-transcription coupling in the nervous
system: involvement of the inducible proto-oncogenes fos and jun. Annu
Rev Neurosci 14:421–451.
Nair SG, Golden SA, Shaham Y (2008) Differential effects of the hypocretin
1 receptor antagonist SB 334867 on high-fat food self-administration and
reinstatement of food seeking in rats. Br J Pharmacol 154:406–416.
Nair SG, Adams-Deutsch T, Epstein DH, Shaham Y (2009a) The neuro-
pharmacology of relapse to food seeking: methodology, main findings,
and comparison with relapse to drug seeking. Prog Neurobiol 89:18–45.
Nair SG, Adams-Deutsch T, Pickens CL, Smith DG, Shaham Y (2009b) Ef-
fects of the MCH1 receptor antagonist SNAP 94847 on high-fat food-
reinforced operant responding and reinstatement of food seeking in rats.
Psychopharmacology 205:129–140.
Nair SG, Navarre BM, Cifani C, Pickens CL, Bossert JM, Shaham Y (2011)
Role of dorsal medial prefrontal cortex dopamine D1-family receptors in
relapse to high-fat food seeking induced by the anxiogenic drug yohim-
bine. Neuropsychopharmacology 36:497–510.
Nance DM (1983) The developmental and neural determinants of the ef-
fects of estrogen on feeding behavior in the rat: a theoretical perspective.
Neurosci Biobehav Rev 7:189–211.
Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates, Ed 5.
Amsterdam: Elsevier Academic.
Peterson CB, Mitchell JE (1999) Psychosocial and pharmacological treat-
ment of eating disorders: a review of research findings. J Clin Psychol
55:685–697.
Pickens CL, Cifani C, Navarre BM, Eichenbaum H, Theberge FR, Baumann
MH, CaluDJ, ShahamY (2012) Effect of fenfluramine on reinstatement
of food seeking in female and male rats: implications for the predictive
validity of the reinstatement model. Psychopharmacology 221:341–353.
Pillitteri JL, Shiffman S, Rohay JM, Harkins AM, Burton SL, Wadden TA
(2008) Use of dietary supplements for weight loss in the United States:
results of a national survey. Obesity (Silver Spring) 16:790–796.
Polivy J, Herman CP (1999) Distress and eating: why do dieters overeat? Int
J Eat Disord 26:153–164.
Polivy J, Coleman J, Herman CP (2005) The effect of deprivation on food
cravings and eating behavior in restrained and unrestrained eaters. Int J
Eat Disord 38:301–309.
Richards JK, Simms JA, Steensland P, Taha SA, Borgland SL, Bonci A, Bartlett
SE (2008) Inhibition of orexin-1/hypocretin-1 receptors inhibits
yohimbine-induced reinstatement of ethanol and sucrose seeking in
Long-Evans rats. Psychopharmacology 199:109–117.
Selye H (1956) The stress of life. New York: McGraw-Hill.
Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003) The reinstatement
model of drug relapse: history, methodology andmajor findings. Psycho-
pharmacology 168:3–20.
ShalevU,MarinelliM, BaumannMH, Piazza PV, ShahamY (2003) The role
of corticosterone in food deprivation-induced reinstatement of cocaine
seeking in the rat. Psychopharmacology 168:170–176.
Shepard JD, Bossert JM, Liu SY, Shaham Y (2004) The anxiogenic drug
yohimbine reinstates methamphetamine seeking in a rat model of drug
relapse. Biol Psychiatry 55:1082–1089.
Stewart J,Woodside BC, ShahamY (1996) Changes in ovarian hormones do
not affect the initiation of intravenous self-administration of heroin in the
female rat. Psychobiology 24:154–159.
Suemaru S,DallmanMF,DarlingtonDN,CascioCS, Shinsako J (1989) Role of
alpha-adrenergic mechanism in effects of morphine on the hypothalamo-
pituitary-adrenocortical and cardiovascular systems in the rat. Neuroendo-
crinology 49:181–190.
UnglessMA,Whistler JL,Malenka RC, Bonci A (2001) Single cocaine expo-
sure in vivo induces long-termpotentiation in dopamine neurons.Nature
411:583–587.
Van den Oever MC, Goriounova NA, Li KW, Van der Schors RC, Binnekade
R, Schoffelmeer AN, Mansvelder HD, Smit AB, Spijker S, De Vries TJ
(2008) Prefrontal cortex AMPA receptor plasticity is crucial for cue-
induced relapse to heroin-seeking. Nat Neurosci 11:1053–1058.
Van denOeverMC, Lubbers BR,GoriounovaNA, Li KW,Van der Schors RC,
LoosM, RigaD,Wiskerke J, BinnekadeR, StegemanM, Schoffelmeer AN,
Mansvelder HD, Smit AB, De Vries TJ, Spijker S (2010a) Extracellular
matrix plasticity and GABAergic inhibition of prefrontal cortex pyrami-
dal cells facilitates relapse to heroin seeking. Neuropsychopharmacology
35:2120–2133.
Van denOeverMC, Spijker S, Smit AB, De Vries TJ (2010b) Prefrontal cortex
plasticity mechanisms in drug seeking and relapse. Neurosci Biobehav
Rev 35:276–284.
Wang Y, Zhang QJ, Liu J, Ali U, Gui ZH, Hui YP, Wang T, Chen L, Li Q
(2010) Noradrenergic lesion of the locus ceruleus increases the firing
activity of the medial prefrontal cortex pyramidal neurons and the role of
alpha2-adrenoceptors in normal and medial forebrain bundle lesioned
rats. Brain Res 1324:64–74.
Wolf ME, Ferrario CR (2010) AMPA receptor plasticity in the nucleus ac-
cumbens after repeated exposure to cocaine. Neurosci Biobehav Rev
35:185–211.
Wu LJ, Kim SS, Li X, Zhang F, Zhuo M (2009) Sexual attraction enhances
glutamate transmission in mammalian anterior cingulate cortex. Mol
Brain 2:9.
Yassin L, Benedetti BL, Jouhanneau JS, Wen JA, Poulet JF, Barth AL (2010)
An embedded subnetwork of highly active neurons in the neocortex.
Neuron 68:1043–1050.
8490 • J. Neurosci., June 20, 2012 • 32(25):8480–8490 Cifani, Koya et al. • c-fos-GFP Transgenic Female Rats and Food Seeking
